Explore how Targeted Protein Degradation (TPD) is revolutionizing the treatment of neurodegenerative diseases by eliminating toxic proteins rather than just inhibiting them.
Revolutionary eEF2K degrader shows promising therapeutic efficacy against triple-negative breast cancer through targeted protein degradation technology.